Cite
HARVARD Citation
Kimby, E. et al. (n.d.). Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas. Leukemia & lymphoma. 56 (9), pp. 2598-2607. [Online].